Avoid engaging in hazardous occupations requiring complete mental alertness such as driving or operating machinery when taking azelastine HCl nasal spray 0.1%. Limited data from post-marketing ...

Treatment-emergent AEs occurred in 8.8% of participants after the bumetanide nasal spray, as compared with 9.1% and 17.9% with the IV and oral formulations, respectively. None of the treatment ...